Utah Medical Products (NASDAQ:UTMD) Now Covered by StockNews.com Analysts
StockNews.com began covering stocks of Utah Medical Products (NASDAQ:UTMD – Get an Assessment) in a report released Thursday. The company has set a “strong buy” rating on the medical device supplier’s stock.
NASDAQ UTMD opened at $89.00 on Thursday. The company has a market capitalization of $324.94 million, a PE ratio of 21.98 and a beta of 0.21. The company’s 50-day moving average is $91.39 and its 200-day moving average is $96.60. Utah Medical Products has a fifty-two week low of $81.01 and a fifty-two week high of $133.87.
Utah Medical Products (NASDAQ:UTMD – Get Rating) last reported results on Tuesday, February 1. The medical device supplier reported earnings per share of $1.13 for the quarter. The company had revenue of $12.91 million for the quarter. Utah Medical Products had a return on equity of 13.78% and a net margin of 30.14%.
Although it has crippled the world, Covid-19 could be the best thing that has ever happened to healthcare. Not only did this expose a gaping hole in our healthcare system, but it also created one of the most explosive investment opportunities since technology.
This $250 billion market is ripe for investors to explore new opportunities.
Several institutional investors have recently changed their positions in UTMD. HealthInvest Partners AB bought a new position in Utah Medical Products stock in the third quarter, valued at approximately $3,899,000. FMR LLC increased its position in Utah Medical Products shares by 2.4% in the first quarter. FMR LLC now owns 488,255 shares of the medical device supplier valued at $43,089,000 after acquiring an additional 11,248 shares last quarter. Allspring Global Investments Holdings LLC bought a new position in Utah Medical Products stock in the fourth quarter, valued at approximately $1,086,000. Martingale Asset Management LP bought a new position in Utah Medical Products stock in the third quarter worth about $336,000. Finally, Globeflex Capital LP increased its position in Utah Medical Products shares by 53.3% in the fourth quarter. Globeflex Capital LP now owns 9,710 shares of the medical device supplier valued at $971,000 after acquiring 3,374 additional shares last quarter. Institutional investors and hedge funds own 71.51% of the company’s shares.
Utah Medical Products Company Profile (Get a rating)
Utah Medical Products, Inc. engages in the manufacture, development, and marketing of disposable and reusable medical devices. It focuses on health care for women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal intensive care, perinatology and urology.
Read more
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Utah Medical Products right now?
Before you consider Utah Medical Products, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Utah Medical Products was not on the list.
While Utah Medical Products currently has an “N/A” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here